Delivery Order SPE2DB20D9759-SPE2DB23FD5MV
Award Date 4/26/23
Potential Completion Date 5/17/23
Potential Value $3.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc. was awarded a firm fixed price delivery order against an unspecified government-wide acquisition contract on April 6, 2023. The $3,021.72 order is for the delivery of 4560647415 units of Lucentis 0.5 mg/0.05 ml syringes to the Defense Logistics Agency in Park Ridge, Illinois. Performance is required by April 27, 2023. No set-aside designation was applied to this order for the pharmaceutical products, which will support the Defense Logistics Agency's medical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract for $1,866.48 to supply Lucentis 0.5 mg/0.05ml. The delivery order has a completion date of December 14, 2023 and was awarded on November 28, 2023 without a set-aside designation. DMS Pharmaceutical Group will provide the specified pharmaceutical item to Defense Logistics Agency Troop Support Medical facilities located in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,544.44, is for the delivery of Lucentis 0.5 mg/0.05 ml syringes to support the medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order (SPE2DX24F5ZZU) valued at $11,583.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide Lucentis 0.5 mg/0.05 ml syringes. This delivery order is part of a larger indefinite delivery contract (SPE2DB), valued up to $499,999,999, that DMS Pharmaceutical Group holds with the DLA to supply a comprehensive range of pharmaceutical products to support the recurring medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,544.44, is for the supply of the pharmaceutical product Lucentis 0.5 mg/0.05 ml syringe 0.05 ml. DMS Pharmaceutical Group holds a significant single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The $15,444.40 contract is for the delivery of LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML, a pharmaceutical product, by March 12, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract with the DLA, valued up to $4,999,999 through 2025, to provide a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,444.40 firm fixed-price delivery order contract is for the purchase of the drug Lucentis 0.5 mg/0.05 ml syringe. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA to issue...
- This is a delivery order (SPE2DB20D9759|SPE2DB24FD5MT) awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) for the supply of Lucentis 0.5 mg/0.05 ml syringes. The $4,633.32 firm fixed-price contract has a completion date of September 25, 2024. DMS Pharmaceutical Group is a key supplier to the Department of Defense (DoD) and Department of Veterans Affairs (VA) medical facilities, providing a wide range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,544.44 firm fixed-price delivery order is for the supply of LUCENTIS 0.5 MG/0.05 ML syringes, with a completion date of October 8, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,071.52 firm fixed-price delivery order is for LUCENTIS 0.3 MG/0.05 ML SYRING 0.05ML, with a performance period ending on August 23, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...